Drug intelligence / Profile preview

levobupivacaine + fentanyl

Development stage
Unknown
Lead developer
CellTech Group
Modality
Small Molecules
Administration
Epidural, Intrathecal
01

Overview

Levobupivacaine + fentanyl is a combination of two drugs used primarily for regional anesthesia and analgesia, especially in procedures such as spinal or epidural anesthesia. Levobupivacaine is a long-acting amide-type local anesthetic that works by reversibly inhibiting sodium channels at the nodes of Ranvier in myelinated neurons, thereby blocking nerve impulse conduction and producing loss of sensation. Fentanyl is a potent synthetic opioid analgesic that acts mainly as an agonist at the mu-opioid receptor, leading to inhibition of pain pathways in the central nervous system. When combined, these agents provide faster onset and prolonged duration of sensory and motor block with enhanced postoperative analgesia compared to levobupivacaine alone[1][6]. This combination is commonly used for infraumbilical surgeries and labor analgesia due to its efficacy and safety profile[1][6].

Other names
levobupivacaine and fentanylfentanyl with levobupivacaine
02

Targets

MOR (Mu opioid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on levobupivacaine + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on levobupivacaine + fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call